UK MedTech wearable wins global award in $150bn sector

UK MedTech wearable wins global award in $150bn sector

ViCardio®, a unique blood pressure monitor developed in the UK, has beaten global competition in the prestigious IDTechEx awards, held in Berlin. The judges were impressed by Tarilian Laser Technologies’ patented biosensor used in ViCardio, which is central in allowing ViCardio® to be the world’s first non-invasive, beat-to-beat, blood pressure monitor. Winning the Best New Wearable Technology Device Award at IDTechEx comes on the back of parent company, Tarilian Laser Technologies (TLT), being just one of six firms chosen by PwC to represent the UK in the Great Festival of Innovation in Hong Kong last month. TLT & ViCardio CEO Dr Sandeep Shah said:
“We are delighted to win the Best New Wearable Technology Award, especially coming so quickly after being part of the delegation to Hong Kong. This reflects the potential of ViCardio®  to transform the patient experience, as well as the strength of the UK technology sector. The global wearables market is growing rapidly and we’re confident that ViCardio® will become a key player in the sector, creating valuable export opportunities and jobs along the way.”
IDTechEx have estimated that the global wearable technology will reach over $150bn annually by 2027, across a number of categories, including medical devices, fitness trackers and smartwatches. UK companies such as TLT are well-placed to take advantage of this growing market. The judges at IDTechEx, Matthew Heasley, from GSK, and Dr Akira Sakaigawa, from Huawei commented that
“ViCardio’s device has the potential to be revolutionary in blood pressure monitoring, so we are delighted to recognise this potential via this award.”
Dr David Pearce, accepting the award in Berlin, said:
“We’re very proud to have been honoured by the largest emerging technologies conference in Europe. UK wearables technology is becoming a global leader and we are playing a major part in that growth.”
Comments are closed.